Gemini Therapeutics, Inc. - Common Stock (NQ:GMTX)

N/A UNCHANGED

Last Price Updated: 3:59 PM EST, Dec 29, 2022 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Gemini Therapeutics, Inc. - Common Stock

< Previous 1 2 3 Next >

Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Gemini Therapeutics, Inc. (GMTX) Investigation

February 21, 2023

From Bronstein, Gewirtz & Grossman, LLC

Via Business Wire

Why Minerva Surgical Shares Are Trading Higher By 166%; Here Are 26 Stocks Moving Premarket ↗

December 28, 2022

Gainers Minerva Surgical, Inc. (NASDAQ: UTRS) shares rose 166% to $0.4327 in pre-market trading after the company reported a $30 million private placement of common stock led by Accelmed Partners.

Via Benzinga

7 Short-Squeeze Stocks for Bold Contrarians to Consider ↗

November 21, 2022

While market volatility has brough the bears out of hibernation, certain short-squeeze stocks could be a trap for the pessimists.

Via InvestorPlace

Gemini Therapeutics Announces Reverse Merger Pact With Hematology-Focused Company ↗

August 10, 2022

Via Benzinga

GEMINI THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Gemini Therapeutics, Inc. - GMTX

August 12, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

GMTX Stock Alert: Halper Sadeh LLP Is Investigating Whether the Merger of Gemini Therapeutics, Inc. Is Fair to Shareholders

August 10, 2022

From Halper Sadeh LLP

Via Business Wire

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 10, 2022

Via Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial ↗

August 10, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

Why Invitae Climbed Around 279%; Here Are 98 Biggest Movers From Yesterday ↗

August 11, 2022

Gainers Invitae Corporation (NYSE: NVTA) surged 278.5% to close at $8.63 after the company reported better-than-expected Q2 EPS.

Via Benzinga

Gemini Therapeutics and Disc Medicine Announce Merger Agreement

August 10, 2022

From Gemini Therapeutics, Inc.

Via Business Wire

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More ↗

April 14, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours:

Via Benzinga

10 Biggest Price Target Changes For Friday ↗

March 11, 2022

Needham cut the price target on OppFi Inc. (NYSE: OPFI) from $10 to $4.5. OppFi shares rose 5.3% to $3.20 in pre-market trading.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 11, 2022 ↗

March 11, 2022

Upgrades According to B of A Securities, the prior rating for Sabra Health Care REIT Inc (NASDAQ:SBRA) was changed from Underperform to Neutral. In the fourth quarter, Sabra...

Via Benzinga

What 5 Analyst Ratings Have To Say About Gemini Therapeutics ↗

March 03, 2022

Within the last quarter, Gemini Therapeutics (NASDAQ:GMTX) has observed the following analyst ratings: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 3, 2022 ↗

March 03, 2022

Upgrades For Douglas Emmett Inc (NYSE:DEI), Evercore ISI Group upgraded the previous rating of In-Line to Outperform. For the fourth quarter, Douglas Emmett had an EPS of $0.48,...

Via Benzinga

10 Biggest Price Target Changes For Thursday ↗

March 03, 2022

Piper Sandler cut the price target on Bright Health Group, Inc. (NYSE: BHG) from $10 to $5. Bright Health shares rose 3.2% to $2.59 in pre-market trading.

Via Benzinga

Read Why Did Jefferies Downgrade Gemini Therapeutics To Hold ↗

March 01, 2022

Jefferies has cut Gemini Therapeutics Inc (NASDAQ: GMTX) to Hold as the Company explores alternatives. The analyst Chris Howerton has also reduced the price target...

Via Benzinga

Stocks That Hit 52-Week Lows On Tuesday ↗

March 01, 2022

During Tuesday's trading, 98 companies set new 52-week lows. Intriguing Points From Today's 52-Week Lows And Highs: JPMorgan Chase (NYSE:JPM) was the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For March 1, 2022 ↗

March 01, 2022

Upgrades Stifel upgraded the previous rating for Revolution Medicines Inc (NASDAQ:RVMD) from Hold to Buy. For the fourth quarter, Revolution Medicines had an EPS of $0.71,...

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

March 01, 2022

Keybanc cut the price target on Workday, Inc. (NASDAQ: WDAY) from $345 to $312. Workday shares rose 5.7% to $242.00 in pre-market trading.

Via Benzinga

Gemini Therapeutics Provides Corporate Update

February 28, 2022

From Gemini Therapeutics, Inc.

Via Business Wire

Gemini Therapeutics Provides GEM103 Program Update

January 10, 2022

From Gemini Therapeutics, Inc.

Via Business Wire

46 Biggest Movers From Yesterday ↗

December 16, 2021

Gainers Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) gained 34.1% to settle at $12.58 on Wednesday. CMC Materials, Inc. (NASDAQ: CCMP) climbed 33.9% to close at $195.50 on...

Via Benzinga

Mid-Afternoon Market Update: Dow Surges Over 100 Points After Federal Reserve's Policy Update ↗

December 15, 2021

Toward the end of trading Wednesday, the Dow traded up 0.35% to 35,669.27 while the NASDAQ rose 0.44% to 15,304.76. The S&P also rose, gaining 0.51% to 4,657.83. The U.S. has...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

December 15, 2021

Gainers Biofrontera (NASDAQ:

Via Benzinga

Gemini Therapeutics Shares Jump As HC Wainwright Sees Over 500% Upside ↗

December 15, 2021

H.C. Wainwright initiated coverage of Gemini Therapeutics Inc (NASDAQ: GMTX) with a Buy rating and $20 price target. In the near term, the expected...

Via Benzinga

Mid-Day Market Update: REV Group Drops After Q4 Results; CMC Materials Shares Climb ↗

December 15, 2021

Midway through trading Wednesday, the Dow traded down 0.30% to 35,436.90 while the NASDAQ fell 0.57% to 15,150.48. The S&P also fell, dropping 0.23% to 4,623.57. The U.S. has...

Via Benzinga

36 Stocks Moving In Wednesday's Mid-Day Session ↗

December 15, 2021

Gainers Nxt-ID, Inc. (NASDAQ: NXTD) shares gained 28.9% to $3.21 after the company said it was awarded U.S. General Services Administration contract to distribute personal...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021 ↗

December 15, 2021

Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

December 15, 2021

Gainers Gemini Therapeutics (NASDAQ:GMTX) shares moved upwards by 32.92% to $3.23 during Wednesday's pre-market session. The market value of their outstanding shares...

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.